NOVO.B.DK

246.95

0%↓

GMAB.DK

1,707

-2.43%↓

HLUNB.DK

37.36

-0.43%↓

AMBUB.DK

71.95

+0.84%↑

ZEAL.DK

269.6

+2.43%↑

NOVO.B.DK

246.95

0%↓

GMAB.DK

1,707

-2.43%↓

HLUNB.DK

37.36

-0.43%↓

AMBUB.DK

71.95

+0.84%↑

ZEAL.DK

269.6

+2.43%↑

NOVO.B.DK

246.95

0%↓

GMAB.DK

1,707

-2.43%↓

HLUNB.DK

37.36

-0.43%↓

AMBUB.DK

71.95

+0.84%↑

ZEAL.DK

269.6

+2.43%↑

NOVO.B.DK

246.95

0%↓

GMAB.DK

1,707

-2.43%↓

HLUNB.DK

37.36

-0.43%↓

AMBUB.DK

71.95

+0.84%↑

ZEAL.DK

269.6

+2.43%↑

NOVO.B.DK

246.95

0%↓

GMAB.DK

1,707

-2.43%↓

HLUNB.DK

37.36

-0.43%↓

AMBUB.DK

71.95

+0.84%↑

ZEAL.DK

269.6

+2.43%↑

Search

Coloplast A-S (Class B)

Suletud

447.5 1.52

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

440.3

Max

450.8

Põhinäitajad

By Trading Economics

Sissetulek

522M

1.4B

Müük

83M

7B

P/E

Sektori keskmine

25.385

61.417

Aktsiakasum

6.32

Dividenditootlus

4.98

Kasumimarginaal

19.835

Töötajad

16,983

EBITDA

309M

2.3B

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+11.86% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

4.98%

2.40%

Järgmine tulemuste avaldamine

12. mai 2026

Järgmine dividendimakse kuupäev

20. mai 2026

Järgmine aktsia dividendi kuupäev (ex-date)

18. mai 2026

Turustatistika

By TradingEconomics

Turukapital

-17B

101B

Eelmine avamishind

445.98

Eelmine sulgemishind

447.5

Coloplast A-S (Class B) Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

13. märts 2026, 19:08 UTC

Uudisväärsed sündmused

TotalEnergies Shutting Production in Qatar, Iraq Amid Fighting in Middle East

13. märts 2026, 18:48 UTC

Tulu
Suurimad hinnamuutused turgudel

Capricor Therapeutics Falls on Wider-Than-Expected 4Q Loss

13. märts 2026, 17:10 UTC

Uudisväärsed sündmused

Week Ahead for FX, Bonds: Central Bank Decisions in Focus After Jump in Energy Prices

13. märts 2026, 17:10 UTC

Uudisväärsed sündmused

Week Ahead for FX, Bonds: Central Bank Decisions -2-

13. märts 2026, 16:47 UTC

Uudisväärsed sündmused

The Week in Oil: Hormuz Crisis Pushes Brent Above $100

13. märts 2026, 22:27 UTC

Market Talk
Uudisväärsed sündmused

Bahrain Faces Uncertainty But Has Support Amid War, S&P Says -- Market Talk

13. märts 2026, 22:13 UTC

Market Talk
Uudisväärsed sündmused

Saudi Arabia Seen as Able to Weather Iran Conflict, S&P Says -- Market Talk

13. märts 2026, 22:04 UTC

Market Talk
Uudisväärsed sündmused

Emirate of RAK Outlook Stable Despite Iran War, S&P Says -- Market Talk

13. märts 2026, 22:00 UTC

Omandamised, ülevõtmised, äriostud

Trump Administration Set to Receive $10 Billion Fee for Brokering TikTok Deal -- WSJ

13. märts 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

13. märts 2026, 20:50 UTC

Market Talk
Uudisväärsed sündmused

Financial Services Roundup: Market Talk

13. märts 2026, 20:02 UTC

Market Talk

Canada Rate Hike in 2026 Would Mark 'Extraordinarily Bad' Policy -- Market Talk

13. märts 2026, 19:50 UTC

Market Talk
Uudisväärsed sündmused

Oil Posts Weekly Gains As Middle East Conflict Drags On -- Market Talk

13. märts 2026, 19:35 UTC

Uudisväärsed sündmused

Oil Prices Hover Near $100. India Asks Iran to Allow 23 Tankers Through Strait of Hormuz. -- Barrons.com

13. märts 2026, 19:00 UTC

Market Talk

U.S. Natural Gas Futures Settle Lower -- Market Talk

13. märts 2026, 18:49 UTC

Uudisväärsed sündmused

The Iran War Could Upend AI. Here's How. -- Barrons.com

13. märts 2026, 18:24 UTC

Uudisväärsed sündmused

Impact of Middle East Conflict on TotalEnergies Activities

13. märts 2026, 18:00 UTC

Uudisväärsed sündmused

Is War Good For the Economy? -- WSJ

13. märts 2026, 17:23 UTC

Market Talk

U.S. Oil Rig Count Rises by 1 to 412 -- Market Talk

13. märts 2026, 16:46 UTC

Market Talk
Uudisväärsed sündmused

European Indexes End Week Lower as Oil Takes Driving Seat -- Market Talk

13. märts 2026, 16:38 UTC

Uudisväärsed sündmused

Higher Oil Prices Could Bring a Global Economic Shock. This Is the Number to Watch. -- Barrons.com

13. märts 2026, 16:34 UTC

Omandamised, ülevõtmised, äriostud

EQT Says It Received Around CHF21 Bln in Total From Galderma Share Sales

13. märts 2026, 16:33 UTC

Omandamised, ülevõtmised, äriostud

EQT Receives Proceeds of Around CHF1.3B From Sell-Down

13. märts 2026, 16:32 UTC

Omandamised, ülevõtmised, äriostud

EQT Completes Exit From Galderma

13. märts 2026, 16:20 UTC

Market Talk
Uudisväärsed sündmused

Financial Services Roundup: Market Talk

13. märts 2026, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

13. märts 2026, 16:15 UTC

Uudisväärsed sündmused

Why Exxon and Energy Stocks Finally Started to Rise This Week as the Iran War Escalated -- Barrons.com

13. märts 2026, 16:11 UTC

Market Talk

Carney Tries to Put Dismal Canada Jobs Data in Context -- Market Talk

13. märts 2026, 16:00 UTC

Uudisväärsed sündmused

Here's Where the U.S. Economy Is Most Vulnerable to Iran War -- WSJ

13. märts 2026, 15:48 UTC

Market Talk
Uudisväärsed sündmused

Oil Futures Turn Higher as Supply Worries Remain -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Coloplast A-S (Class B) Prognoos

Hinnasiht

By TipRanks

11.86% tõus

12 kuu keskmine prognoos

Keskmine 901.38 DKK  11.86%

Kõrge 1,056 DKK

Madal 720 DKK

Põhineb 8 Wall Streeti analüütiku instrumendi Coloplast A-S (Class B) 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

8 ratings

2

Osta

4

Hoia

2

Müü

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat